| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Nicholas Bonomo, Irem Hacisalihoglu Aydin, Rif S El-Mallak. Does serotonin reuptake inhibition provoke catatonia in patients with bipolar illness? Bipolar disorders. 2024-05-14. PMID:38744682. |
does serotonin reuptake inhibition provoke catatonia in patients with bipolar illness? |
2024-05-14 |
2024-05-27 |
Not clear |
| Anıl Alp, Melike Karaçam Doğan, Elçin Özçelik Eroğlu, Mevhibe İrem Yildiz, Şeref Can Gürel, Suzan Öze. Transient Fever Response After ECT in a Patient with Catatonic Schizophrenia: A Case Report. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 35. issue 1. 2024-04-01. PMID:38556940. |
fever; in addition to general medical conditions such as infection, malignancy, connective tissue diseases, drug treatments, malignant hyperthermia, convulsions, it can also occur due to conditions such as neuroleptic malignant syndrome (nms), serotonin syndrome, catatonia, malignant catatonia, which are frequently encountered in psychiatry clinics. |
2024-04-01 |
2024-04-03 |
Not clear |
| Howie Wu, Vanessa Hil. Serotonin Syndrome and Catatonia in the Absence of a Serotonergic Agent Following Abrupt Withdrawal of Clozapine. The Canadian journal of hospital pharmacy. vol 77. issue 1. 2024-02-15. PMID:38357300. |
serotonin syndrome and catatonia in the absence of a serotonergic agent following abrupt withdrawal of clozapine. |
2024-02-15 |
2024-02-17 |
Not clear |
| Adela G Buciuc, Paula Traugott, Carlos R Dange. An Unusual Presentation of Serotonin Syndrome and Subsequent Catatonia in a Patient With a Family History of Huntington's Disease. Cureus. vol 15. issue 9. 2023-09-18. PMID:37720123. |
we present the case of a 48-year-old woman with an unusual presentation of serotonin syndrome and subsequent catatonia possibly overlapping with a neurodegenerative disorder, hd. |
2023-09-18 |
2023-10-07 |
Not clear |
| Adela G Buciuc, Paula Traugott, Carlos R Dange. An Unusual Presentation of Serotonin Syndrome and Subsequent Catatonia in a Patient With a Family History of Huntington's Disease. Cureus. vol 15. issue 9. 2023-09-18. PMID:37720123. |
an unusual presentation of serotonin syndrome and subsequent catatonia in a patient with a family history of huntington's disease. |
2023-09-18 |
2023-10-07 |
Not clear |
| Laura A Ketigian, Shantanu S Kidamb. Postoperative Catatonia After Fentanyl, Hydromorphone, and Ketamine Administration in a Patient Taking Sertraline: A Case Report. A&A practice. vol 17. issue 7. 2023-07-18. PMID:37463280. |
differential diagnoses and etiologies discussed reveal a possible multifactorial catatonia mechanism involving opioids, ketamine, and serotonin. |
2023-07-18 |
2023-08-14 |
Not clear |
| Mohammad Abu-Abaa, Dhay Bahadli, Osamah Abdulhussein, Ali Abdulsahib, Daniel Landa. Cefepime-Induced Neurotoxicity Can Be Confused With Neuroleptic Malignant Syndrome, Catatonia and Serotonin Syndrome: A Case Report. Cureus. vol 15. issue 1. 2023-02-28. PMID:36852358. |
cefepime-induced neurotoxicity can be confused with neuroleptic malignant syndrome, catatonia and serotonin syndrome: a case report. |
2023-02-28 |
2023-08-14 |
Not clear |
| Manuel Pereira Herrera, Aphrodite Marta Zimmerma. Case of refractory delirious mania responsive to lithium. BJPsych open. vol 7. issue 4. 2021-07-20. PMID:34184627. |
more often seen in patients with a history of bipolar disorder, it frequently presents with prominent catatonic features and overlaps with other diseases in the catatonic spectrum, such as neuroleptic malignant syndrome, serotonin syndrome and malignant catatonia. |
2021-07-20 |
2023-08-13 |
Not clear |
| Diana Apetauerova, Pritika A Patel, Joseph D Burns, David P Lerne. Movement Disorder Emergencies. Neurologic clinics. vol 39. issue 2. 2021-06-22. PMID:33896535. |
inadvertent or purposeful overdose of many psychiatric medications can result in acute life-threatening movement disorders including serotonin syndrome, neuroleptic malignant syndrome, and malignant catatonia. |
2021-06-22 |
2023-08-13 |
Not clear |
| Rikinkumar S Patel, Nikhila Veluri, Geetika Verm. Mirtazapine Creating "Miracles" in Psychotic Depression With Catatonia. Cureus. vol 12. issue 8. 2020-09-28. PMID:32963904. |
treatment for catatonia due to depression includes serotonin reuptake inhibitors (ssris). |
2020-09-28 |
2023-08-13 |
Not clear |
| Suraj Rajan, Bonnie Kaas, Emile Moukheibe. Movement Disorders Emergencies. Seminars in neurology. vol 39. issue 1. 2019-04-15. PMID:30743298. |
here we review the clinical phenomenology, and diagnostic principles of neuroleptic malignant syndrome, malignant catatonia, serotonin syndrome, parkinsonism hyperpyrexia, acute parkinsonism, acute chorea-ballism, drug-induced dystonia, and status dystonicus. |
2019-04-15 |
2023-08-13 |
Not clear |
| E M Peter-Ros. Molecular hypotheses to explain the shared pathways and underlying pathobiological causes in catatonia and in catatonic presentations in neuropsychiatric disorders. Medical hypotheses. vol 113. 2018-10-15. PMID:29523295. |
furthermore, snord115 genes may underlie a genetic vulnerability when environmental triggers result in excess serotonin producing the serotonin syndrome, a condition similar to nms in which catatonia may occur. |
2018-10-15 |
2023-08-13 |
Not clear |
| Jambur Ananth, Kamala Aduri, Sharath Parameswaran, Sarath Gunatilak. Neuroleptic malignant syndrome: risk factors, pathophysiology, and treatment. Acta neuropsychiatrica. vol 16. issue 4. 2016-03-18. PMID:26984310. |
differential diagnosis should include malignant hyperthermia, lethal catatonia, lithium toxicity, serotonin syndrome, and heat stroke. |
2016-03-18 |
2023-08-13 |
Not clear |
| Davin Kenneth Quin. "Burn catatonia": a case report and literature review. Journal of burn care & research : official publication of the American Burn Association. vol 35. issue 2. 2014-11-12. PMID:24165667. |
this report describes a case of malignant catatonia occurring in a 51-year-old male patient acutely suffering from burns acquired in a chemical explosion, effectively treated with reinstitution of a selective serotonin reuptake inhibitor. |
2014-11-12 |
2023-08-12 |
Not clear |
| Outi Lapatto-Reiniluoto, Kari Raask. [Drug-associated hyperthermic syndromes]. Duodecim; laaketieteellinen aikakauskirja. vol 129. issue 24. 2014-02-20. PMID:24471206. |
drug-associated hyperthermic syndromes include the serotonin syndrome, neuroleptic malignant syndrome, neuroleptic-induced catatonia, anticholinergic syndrome, sympatomimetic syndrome and malignant hyperthermia. |
2014-02-20 |
2023-08-12 |
Not clear |
| Michele Fornar. Catatonia: a narrative review. Central nervous system agents in medicinal chemistry. vol 11. issue 1. 2011-06-17. PMID:21294706. |
what is clear is that neurotransmitters, such as dopamine (da), gamma-aminobutyric acid (gaba), and glutamate (glu), are of major importance in the pathogenesis of catatonia and neuroleptic malignant syndrome (nms) and that serotonin (5-hydroxytryptamine [5-ht]) is crucial to the development of serotonin syndrome (ss). |
2011-06-17 |
2023-08-12 |
Not clear |
| D V Klochkov, T A Alekhina, N N Barykin. [Monoamines and function of the ovaries in rats selected for elevated catatonic reactivity]. Zhurnal evoliutsionnoi biokhimii i fiziologii. vol 45. issue 3. 2009-09-28. PMID:19569559. |
levels of dopamine (dopa), noradrenalin (na), and serotonin in hypothalamus and function of ovaries (folliculogenesis) were studied at various estrous cycle stages of the rat gk line selected for elevated catatonia. |
2009-09-28 |
2023-08-12 |
rat |
| Brendan T Carroll, Joseph W Y Lee, Kevin T Graham, Arthur Thalassinos, Christopher Thomas, Rob Kirkhar. Diagnosing subtypes of neuroleptic malignant syndrome: an introduction to the Lee-Carroll Scale. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 20. issue 1. 2008-04-07. PMID:18297586. |
neuroleptic malignant syndrome (nms) shares common features with catatonia and serotonin syndrome (ss). |
2008-04-07 |
2023-08-12 |
Not clear |
| Ian J Bagule. The excitatory:inhibitory ratio model (EIR model): An integrative explanation of acute autonomic overactivity syndromes. Medical hypotheses. vol 70. issue 1. 2008-04-01. PMID:17583440. |
these syndromes include neuroleptic malignant syndrome, serotonin syndrome, dysautonomia (or paroxysmal sympathetic storms) following acquired brain injury, autonomic dysreflexia, parkinsonian-hyperpyrexia syndrome, malignant catatonia, intrathecal baclofen withdrawal, malignant hyperthermia, stiff man syndrome and irukandji syndrome. |
2008-04-01 |
2023-08-12 |
Not clear |
| I M K ter Haar, R J Rutgers, P H M Egber. [A young woman with a labile mood, hyperactivity, hyperthermia and exhaustion: symptoms of lethal catatonia]. Nederlands tijdschrift voor geneeskunde. vol 150. issue 32. 2006-09-25. PMID:16948232. |
lethal catatonia must be distinguished from the neuroleptic malignant syndrome, serotonin syndrome and encephalitis. |
2006-09-25 |
2023-08-12 |
Not clear |